论文部分内容阅读
目的评价世可眼内灌注在白内障超声乳化术中的临床应用价值。方法在138例手术中,分别采用美国AlconBSS和沈阳兴齐世可眼内灌注,对比手术中角膜透明性和术后第1、3、7天的角膜透明性以及眼内炎症的变化。结果两组间所有病例术中、术后角膜透明性以及术后眼内炎症未显示明显差异而将两组内各病例分类比较后,显示出合并其他眼病的白内障超声乳化手术者,使用BSS者术后反应轻于使用世可眼内灌注液者,差异有显著性。结论世可眼内灌注液应用在白内障超声乳化术中是安全有效的且符合卫生经济学的规律。
Objective To evaluate the clinical value of intraocular intraocular perfusion in cataract phacoemulsification. Methods The intraocular perfusion of AlconBSS in the United States and Shenyang Hysteria was performed in 138 cases. The changes of corneal transparency and intraocular inflammation on the 1st, 3rd, 7th day postoperatively were compared. Results All cases in both groups intraoperative and postoperative corneal transparency and postoperative intraocular inflammation showed no significant difference between the two groups after the classification of the cases compared with other eye diseases showed cataract phacoemulsification surgery, the use of BSS The postoperative reaction was less than that of intraocular irrigating solution, the difference was significant. Conclusion Intraocular perfusion fluid used in cataract phacoemulsification is safe and effective and in line with the laws of health economics.